• About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • Media
  • Contact
BBC World Service Radio Brisbane Interview with Ellume CEO

BBC World Service Radio Brisbane Interview with Ellume CEO

17 December 2020, Victoria Craig Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by BBC World Service Radio’s Victoria Craig about our innovative Ellume COVID-19 Home Test receiving Emergency Use Authorization from the US FDA and how our products are responding to the COVID-19 pandemic.
Read More
FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

Proven performance in adults and children, with and without symptoms Highlights FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals The test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above Ellume is ramping up manufacture, […]
Read More
Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Highlights Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home test Clinical study demonstrated overall sensitivity of 95% and specificity of 97% Clinically validated for use in symptomatic and asymptomatic users ages 2 years and above Independently run, simulated home-use clinical study of 198 subjects Ellume is […]
Read More
Palaszczuk Government boosts manufacturing capability for Ellume’s world-class COVID-19 rapid tests

Palaszczuk Government boosts manufacturing capability for Ellume’s world-class COVID-19 rapid tests

Highlights Ellume receives strategic investment from Queensland State Government under Essential Goods and Supply Chain Program State Government funding will enable expansion of Ellume’s Brisbane manufacturing facility, the largest of its kind in the Southern Hemisphere Ellume will install multiple state-of-the-art automated production lines to speed up and enhance production capability Production is already underway […]
Read More

ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons

29 October 2020, Richard Aedy Ellume Founder, CEO and Managing Director Dr Sean Parsons was interviewed by ABC Radio’s Richard Aedy on The Money program about how the company is scaling up its Brisbane manufacturing facilities as part of a US push to develop rapid COVID-19 testing technology. This interview originally appeared on ABC Radio […]
Read More
Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Highlights Ellume will collaborate with Bosch to create state-of-the-art automated production lines, to scale up manufacturing volumes of COVID-19 and other diagnostic tests. Bosch capabilities will build resilience and innovation into the local Ellume manufacturing processes. Bosch global automation and manufacturing know-how harnessed to ensure successful industrialisation of Ellume COVID-19 consumable test. New Ellume manufacturing […]
Read More

10 News First reports Ellume’s $42M NIH funding for rapid COVID test

8 October 2020, Samantha Butler Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by 10 News First Queensland’s Samantha Butler on the successful awarding of $42m from the US NIH to Ellume to scale up and fast track the production of its COVID-19 diagnostic tests. This interview originally appeared on 10 […]
Read More
Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Brisbane, Australia — 7 October 2020 Ellume, a leader in rapid digital diagnostics, today announced it was successfully awarded US$30million from the U.S. National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the clinical testing and manufacturing scale-up of the company’s COVID-19 antigen tests. Ellume’s core fluorescent immunoassay platform has been […]
Read More
Ellume announces high-performance test for active COVID-19 infection

Ellume announces high-performance test for active COVID-19 infection

Highlights New high-performance antigen test for active COVID-19 infection, developed by Ellume, provides accurate results in less than 15 minutes Builds on existing QIAGEN partnership to bring another test to market to join the rapid, reliable COVID antibody test as announced last month Easy to use; each device can process over 30 samples per hour, […]
Read More

ABC Radio Brisbane Interview with Ellume CEO, Dr Sean Parsons

31 August 2020, Kelly Higgins-Devine Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by ABC Brisbane Radio’s Kelly Higgins-Devine about how its innovative digital diagnostics are responding to the COVID-19 pandemic. This interview originally appeared on ABC Brisbane radio, “Mornings” program on 31st August 2020. Listen to the full Mornings episode […]
Read More
Page 1 of 3123
Recent Posts
  • BBC World Service Radio Brisbane Interview with Ellume CEO
  • FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test
  • Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study
  • Palaszczuk Government boosts manufacturing capability for Ellume’s world-class COVID-19 rapid tests
  • ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons
Archives
Scroll

ellume logo white

ABN 13 141 767 660
57 Didsbury Street,
East Brisbane, Queensland 4169
Australia

MENU

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
Media

CONTACT US

1800 001 120
+61 7 3393 1448
General Enquiries
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance – NOT AVAILABLE FOR SALE © Ellume Limited 2020